Market Overview

Hearing UBS Says Endo Likely to be Sold at $40+/share.

Share:

Latest Ratings for ENDP

DateFirmActionFromTo
Jun 2017Cantor FitzgeraldInitiates Coverage OnNeutral
Jun 2017Stifel NicolausDowngradesBuyHold
Feb 2017Canaccord GenuityInitiates Coverage OnBuyHold

View More Analyst Ratings for ENDP
View the Latest Analyst Ratings

Posted-In: UBSAnalyst Color News Rumors M&A Analyst Ratings Movers

 

Related Articles (ENDP)